Skip to main content



Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand

  • Aging
  • Antiphospholipid Syndrome
  • COVID-19
  • Crystal arthropathies
  • Diversity, inclusion and racial disparities
  • Epidemiology, health policy and outcomes
  • Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
  • Genetics, genomics and proteomics
  • Hematologic- and oncologic-associated rheumatic syndromes
  • Imaging
  • Immunobiology
  • Immunodeficiencies
  • Infection-related rheumatic syndromes
  • Juvenile idiopathic arthritis (JIA) and pediatric joint disorders
  • Metabolic bone disease
  • Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Orthopedics and Rehabilitation
  • Osteoarthritis (OA) and related disorders
  • Pain syndromes, fibromyalgia and regional musculoskeletal disorders
  • Patient engagement/self-management
  • Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
  • Periodic fever syndromes, autoinflammatory diseases, Still’s disease and MAS/HLH
  • Professional development and education
  • Reproductive health
  • Rheumatic manifestations of systemic diseases (hemochromatosis, Wilson
  • Rheumatoid arthritis (RA)
  • Sjögren’s syndrome
  • Spondyloarthritis (SpA) including psoriatic arthritis (PsA)
  • Systemic lupus erythematosus (SLE)
  • Tech med and telemedicine
  • Vasculitis